European Archives - Page 55 of 1166 - European Medical Journal

Semaglutide Shows Promise in Treating MASH and Liver Fibrosis

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

New Screening Model Enhances Hepatitis Care Access: EASL 2025

The study concludes that decentralised and person-centred hepatitis screening is effective and essential.

BMS names Cari Gallman as new General Counsel

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 years.

Restoring T Cell Autophagy Reduces Liver Fibrosis Progression

A new study sheds light on the role of CD4 T cell autophagy, a cellular recycling process, in the progression of liver fibrosis.

AI Enhances Fracture Risk Prediction in Women Who Are Postmenopausal: WCO 2025

Researchers from the OsteoLaus cohort have developed a machine learning model to predict fragility fractures in postmenopausal women using bone and body composition data.

New Driver of Inflammation Found in Ulcerative Colitis

Clinically, this discovery could reshape the understanding of immune regulation in ulcerative colitis.

Managing Atopic Dermatitis in Infants

Restoring the skin barrier is key in managing and potentially preventing atopic dermatitis.

The word spotlight on a blue background

Spotlight: April 2025

From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.

Breast Cancer Study Tests Surgery-Free Approach

A US trial has shown no local tumour recurrences in patients with exceptional responses to neoadjuvant therapy who skipped breast surgery, offering hope for future de-escalation strategies.

New Treatment Strategy May Boost Survival in T-Cell Lymphomas

A retrospective analysis of global data has found that a specific treatment sequence, starting with small molecule inhibitors and followed by epigenetic modifiers, may significantly improve survival in patients with relapsed or refractory T-cell lymphomas.